Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders (English, HTML)
Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders: English HTML file. From Health Canada, updated Jul 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-07-27
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file